1. Consider changing the amount of your coverage

Quite often getting a bigger amount of insurance coverage will actually give you a lower rate. For example, most companies will offer a $260 annual premium for $250,000 in coverage, while having $245,000 will cost you about $20 more in annual premiums. Make sure to learn what is the premium per every $1000 of your coverage with every particular company you think getting a policy from. This way you will be able to get the most coverage for the lowest price.

2. Look for a compassionate insurance provider

Some insurance carriers tend to offer affordable rates to individuals with conditions such as cancer, diabetes or other serious diseases. It is better to work with a company, the employees of which tend to study each case individually and offer a respective rate rather than giving everyone with the same condition just one price tag.

3. Change your lifestyle

Kicking bad habits like drinking and smoking, starting to exercise regularly and loosing extra weight will put you into a lower risk category and your rates will drop significantly. Some companies charge smokers with a double rate of what non-smoker pay for life insurance. However, you should be absolutely honest with the insurer here, because if you lie and end up having habit-related disease, the company is likely to not pay out your death benefit at all.

4. Drop the riders

Riders are a good way to add up the overall value of your life insurance policy, but in most cases it is just an additional and unnecessary expense. While riders may add value to your life insurance policy in certain situations, many are simply an unnecessary expense. After all, you want to pay less for your policy, so why paying for covering an event that is very unlikely to happen?

5. Learn your hidden fees

Paying in “reasonable” installments on a monthly basis may seem like a nice idea but is likely that you will pay much more for your insurance policy than you think. That’s why it is important to spare some time at comparing both payment options before you actually choose a payment plan for your insurance policy. The math will definitely tell you whether the convenience is too pricey or not.

6. Do the shopping

When looking for insurance offers, comparison shopping is definitely the first thing you have to think about. Compare the offers from different companies – sometimes the rates differ substantially for the same amount of coverage, so make sure you have studies all of the options before getting your policy. There are many sites out there offering life insurance quotes from different providers.

Drugs “thiopurine” or drugs “immunosupressive” that prevents the immune system normally used to treat inflammatory bowels disease, the researchers said. Unfortunately this drug can increase the risk of cancer associated with the virus.

Drugs “immunosupressive” involves actions that reduce the activity or efficacy of the immune system.

Beaugerie Laurent and colleagues at Saint Antoine Hospital in Paris, studied more than 19,000 patients with inflammatory bowels disease. As many as 30 percent of patients using “thiopurines”, 14 percent have stopped using it and 56 percent had never used it.

Having followed the development of all the patients for nearly three years, the researchers found 23 new cases of cancer. One patient attacked “Hodgin’s lumphoma” and 22 more “non-Hodgin lymphoma.

Hodgkin’s lymphoma is a type of lymphoma, cancer that stemmed from white blood cells called “lymphocytes”.

Statistical analysis showed that all patients who receive “thiopurine” like “azathioprine”, which produced several generic drug makers, and by Glaxo SmithKline with the name “Imuran” increases risk of “lymphoma” five times higher than those who never used the drug, the researchers said in the journal “The Lancet”.

Male patients older with a history of inflammatory disease of the stomach contents of older also have increased risk of cancer “lymphoma”.

“The risk of accumulation of absolute … in young patients who receive path” thiopurine “for 10 years remains low, less than 1 percent and not reduce the positive risk benefit ratio of this drug,” the researchers wrote, as reported to the British news agency Reuters.

But for older patients and for the treatment without limit, further studies are needed to assess the risks, they said.

When commenting on these studies, Geert D’Haens from Imelda GI Clinical Research Center and Paul Rutgeerts of the University Hospital Gesthuisberg, both in Belgium, said doctors should be cautious in prescribing the drug “thiopurine” for a long time.

But they said that despite the increased risk of “lymphoma”, the drug “will probably remain one treatment milestone”.